Virtual Reality and Pain
FOREVR Peds
Functional Outcome Response to Engaging Virtual Reality in Pediatric Patients: a Randomized Clinical Trials
1 other identifier
interventional
90
1 country
1
Brief Summary
Determine the impact of VR-Biofeedback, VR-distraction, and 360 video on pain and medication utilization in patients undergoing surgery; determine the role of anxiety and pain catastrophizing on changes in pain following VR-BF in patients undergoing surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 3, 2020
CompletedFirst Posted
Study publicly available on registry
April 17, 2020
CompletedStudy Start
First participant enrolled
July 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2023
CompletedAugust 31, 2023
August 1, 2023
3.1 years
April 3, 2020
August 30, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Effect of VR-biofeedback on pain
Pain scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
Postoperatively 24 - 90 hours.
Effect of VR-distraction on pain
Pain scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
Postoperatively 24 - 90 hours.
Effect of 360 video on pain
Pain scores will be collected. Pain will be rated using the numerical rating scale. Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
Postoperatively 24 - 90 hours.
Secondary Outcomes (11)
Effect of VR-biofeedback on anxiety
Before 10 minute VR session.
Effect of VR-biofeedback on anxiety
After 10 minute VR session. Anxiety will be rated using a visual analog scale.
Effect of VR-biofeedback on medication use
Duration of hospital stay up to 30 days after discharge
Effect of VR-distraction on anxiety
Before 10 minute VR session.
Effect of VR-distraction on anxiety
After 10 minute VR session.
- +6 more secondary outcomes
Study Arms (3)
VR-Biofeedback
OTHERVR-Distraction
OTHER360 Video
OTHERInterventions
Participants will be instructed to use the Mindful Aurora application
Eligibility Criteria
You may qualify if:
- Ages 8 - 18 years
- Able to read, understand and speak English
- Patients in the immediate postoperative period with significant pain being followed by the Acute Pain Service
You may not qualify if:
- Outside the age range (\< 8 or \> 18 years)
- History of developmental delays, uncontrolled psychiatric conditions, or neurological conditions (especially epilepsy and/or significant motion sickness/nausea/vomiting)
- History of vertigo, dizziness, and/or seizure disorder
- Conditions that would preclude the application of the VR headset, such as surgeries of the head and neck
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Related Publications (1)
Olbrecht VA, Williams SE, O'Conor KT, Boehmer CO, Marchant GW, Glynn SM, Geisler KJ, Ding L, Yang G, King CD. Guided relaxation-based virtual reality versus distraction-based virtual reality or passive control for postoperative pain management in children and adolescents undergoing Nuss repair of pectus excavatum: protocol for a prospective, randomised, controlled trial (FOREVR Peds trial). BMJ Open. 2020 Dec 30;10(12):e040295. doi: 10.1136/bmjopen-2020-040295.
PMID: 33380482DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charlotte Walter, MD
Children's Hospital Medical Center, Cincinnati
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 3, 2020
First Posted
April 17, 2020
Study Start
July 10, 2020
Primary Completion
July 30, 2023
Study Completion
July 30, 2023
Last Updated
August 31, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will become available upon publication. All data will be deidentified.
This information will be made available upon request.